Author:
Takegaki Junya,Sase Kohei,Kono Yusuke,Nakano Daiki,Fujita Takuya,Konishi Satoshi,Fujita Satoshi
Abstract
AbstractSkeletal muscle mass is critical for good quality of life. Mesenchymal stem cells (MSCs) are multipotent stem cells distributed across various tissues. They are characterized by the capacity to secrete growth factors and differentiate into skeletal muscle cells. These capabilities suggest that MSCs might be beneficial for muscle growth. Nevertheless, little is known regarding the effects on muscle protein anabolic and catabolic systems of intramuscular injection of MSCs into skeletal muscle. Therefore, in the present study, we measured changes in mechanistic target of rapamycin complex 1 (mTORC1) signaling, the ubiquitin–proteasome system, and autophagy-lysosome system-related factors after a single intramuscular injection of MSCs with green fluorescence protein (GFP) into mouse muscles. The intramuscularly-injected MSCs were retained in the gastrocnemius muscle for 7 days after the injection, indicated by detection of GFP and expression of platelet-derived growth factor receptor-alpha. The injection of MSCs increased the expression of satellite cell-related genes, activated mTORC1 signaling and muscle protein synthesis, and increased protein ubiquitination and autophagosome formation (indicated by the expression of microtubule-associated protein 1 light chain 3-II). These results suggest that the intramuscular injection of MSCs activated muscle anabolic and catabolic systems and accelerated muscle protein turnover.
Funder
Ritsumeikan Global Innovation Research Organization, Ritsumeikan University
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Landi, F. et al. Sarcopenia as a risk factor for falls in elderly individuals: Results from the ilSIRENTE study. Clin. Nutr. 31, 652–658 (2012).
2. Mesinovic, J., Zengin, A., De Courten, B., Ebeling, P. R. & Scott, D. Sarcopenia and type 2 diabetes mellitus: A bidirectional relationship. Diabetes. Metab. Syndr. Obes. 12, 1057–1072 (2019).
3. Atkins, J. L. et al. Sarcopenic obesity and risk of cardiovascular disease and mortality: A population-based cohort study of older men. J. Am. Geriatr. Soc. 62, 253–260 (2014).
4. Denison, H. J., Cooper, C., Sayer, A. A. & Robinson, S. M. Prevention and optimal management of sarcopenia: A review of combined exercise and nutrition interventions to improve muscle outcomes in older people. Clin. Interv. Aging. 10, 859–869 (2015).
5. Haran, P. H., Rivas, D. A. & Fielding, R. A. Role and potential mechanisms of anabolic resistance in sarcopenia. J. Cachexia. Sarcopenia. Muscle. 3, 157–162 (2012).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献